To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
26 Newest Market Studies about the topic liver disease
rss
Fatty Liver Disease Global Clinical Trials Review, H1, 2012
Introduction GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H1, 2012" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It ...
Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2012', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) therapeutic pipeline. This report provides information on the therapeutic development for Non Alcoholic Fatty ...
Fatty Liver Disease – Pipeline Review, H2 2012
Introduction Global Markets Direct’s, 'Fatty Liver Disease - Pipeline Review, H2 2012', provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special ...
Shin Poong Pharm Co., Ltd. - Strategic SWOT Analysis Review
Shin Poong Pharm Co., Ltd.(Shin Poong) is a pharmaceutical company engaged in the development, marketing, and distribution of pharmaceutical products for various diseases. The company’s products include antibiotics, amino acids, gingival agents, antitussives and expectorants, antihistamines, ...
Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review
Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review Summary Medigen Biotechnology Corporation (MBC) is a pharmaceutical company engaged in the research and development of biopharmaceuticals for liver diseases and cancers. MBC provides technology ...
Fatty Liver Disease – Pipeline Review, H1 2012
Introduction Global Markets Direct’s, 'Fatty Liver Disease - Pipeline Review, H1 2012', provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special ...
Tanzania Pharmaceuticals and Healthcare Report Q2 2012
BMI View: We are encouraged by the fact that the Tanzanian government has placed a greater emphasis on development expenditure, highlighting healthcare as a key area of investment, particularly as the country's disease burden is set to increase. However, we are concerned by the continued ...
Fatty Liver Disease - Pipeline Review, Q1 2011
Introduction Global Markets Direct’s, 'Fatty Liver Disease - Pipeline Review, Q1 2011', provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special ...
Human Albumin and Factor Vlll (FVIII) Markets: An Analysis
Introduction The global blood plasma-derived products market has shown consistent growth over the period 2002-2009 and the rapid increase in cases of Hemophilia, low treatment cost to patients and rising ageing population are the major factors that will be driving the market for ...
China Medical System Holdings Limited (CMSH) - Financial and Strategic SWOT Analysis Review
China Medical System Holdings Limited (CMS) is an integrated pharmaceutical group that focuses on the research development, manufacturing and marketing of pharmaceuticals and medical devices. Its products include Deanxit tablets for the treatment of anxiety, depression, asthenia, and ...
Netmeeting
